"The pharmaceutical market has entered a new era, one characterized by more modest growth due to the continuing impact of new generic products, fewer and more narrowly indicated novel medications, and closer scrutiny of safety issues."
Murray Aitken, an IMS senior vice president.
More at The Ledger
No comments:
Post a Comment